Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.36

€0.36

0.700%
0.0025
0.700%
-
 
19.07.24 / Frankfurt WKN: A1JCLA / Name: Mauna Kea / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Mauna Kea Tech Stock

The Mauna Kea Tech stock is trending slightly upwards today, with an increase of €0.003 (0.700%) compared to yesterday's price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Mauna Kea Tech stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Mauna Kea Tech in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Mauna Kea Tech vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Mauna Kea Tech 0.700% 5.394% 2.991% -40.931% -18.120% -64.066% -79.104%
Intrasense -2.830% 2.612% 7.422% -36.927% -15.902% -57.594% -
InVivo Therapeutics Holdings -2.480% 9.790% -6.548% -71.964% -54.360% -99.934% -99.934%
Atossa Genetics Inc 0.160% 11.232% 17.850% 21.464% 30.499% -65.889% -67.201%

News

Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances: https://mms.businesswire.com/media/20240626399128/en/337855/5/mkt_logo_bg_1024-300dpi.jpg
Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances


Regulatory News:



Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary platform for probe-based and needle-based confocal laser endomicroscopy (p/nCLE)